{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:34:33Z","timestamp":1786624473880,"version":"build-2736575974"},"reference-count":236,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cervical cancer (CC) ranks as the fourth most prevalent malignancy among women. High-risk human papillomavirus (HPV) infection is a significant contributor to CC in economically disadvantaged nations. The incidence of CC may be significantly reduced by preventive measures, and early detection is strongly associated with improved survival rates. CC presents a substantial danger to women in low- and middle-income countries who often have severe and untreatable sicknesses due to limited resources.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Inflammatory markers, such as platelet count, platelet-to-lymphocyte ratio, and IL-6 tumoral expression, indicate a worse likelihood of survival in individuals with CC. Single nucleotide polymorphisms in cytokine genes have been linked to an increased risk of CC. Cytokines such as IL-12, IL-6, and IL-10 may serve as biomarkers for CC. The prognosis of CC may also be influenced by DNA methylation. Immune cells possess a unique ability to combat tumors, and their interactions with tumor growth and invasion significantly impact prognosis and treatment. Genetic biomarkers, such as circulating cell-free or cellular DNA, RNA, SNPs, and epigenetic biomarkers like microRNA and DNA methylation, have the potential to forecast the likelihood of developing a disease. Protein and cell biomarkers, such as cytokines, hormones, and enzymes, have the potential to detect cancer at an early stage and provide accurate diagnosis and prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review focuses on evaluating several inflammatory biomarkers with potential use in diagnosing and targeting specific therapeutic interventions for the successful treatment of CC, highlighting the attractive prospects of their medicinal utilization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1806448","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:02:15Z","timestamp":1786622535000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Recent advancement in inflammatory biomarkers for cervical cancer diagnosis and therapy"],"prefix":"10.3389","volume":"16","author":[{"given":"Utkarsha","family":"Sahu","sequence":"first","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences","place":["Bhopal, Madhya, India"]},{"name":"Xenesis Institute, Absolute","place":["Gurugram, Haryana, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet","family":"Singh","sequence":"additional","affiliation":[{"name":"Cell and Molecular Biology Laboratory, Department of Zoology, Soban Singh Jeena University","place":["Almora, Uttarakhand, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences","place":["Bhopal, Madhya, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Samant","sequence":"additional","affiliation":[{"name":"Department of Zoology, DSB Campus, Kumaun University","place":["Nainital, Uttarakhand, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Khare","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences","place":["Bhopal, Madhya, India"]},{"name":"Xenesis Institute, Absolute","place":["Gurugram, Haryana, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jncc.2024.11.006","article-title":"Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022","volume":"5","author":"Wu","year":"2025","journal-title":"J Natl Cancer Center"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gloepi.2025.100233","article-title":"Cervical cancer burden in India: a descriptive epidemiological study and policy insights","volume":"10","author":"Singh","year":"2025","journal-title":"Glob Epidemiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2023.105214","article-title":"High-risk human papillomavirus distribution in different cytological classification women","volume":"25","author":"Zheng","year":"2023","journal-title":"Microbes Infection"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1633283","article-title":"Human papillomavirus-mediated cervical cancer: epigenetic interplay and clinical implications","volume":"16","author":"Sisodiya","year":"2025","journal-title":"Front Microbiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02896","article-title":"Involvement of human papillomaviruses in cervical cancer","volume":"9","author":"Wang","year":"2018","journal-title":"Front Microbiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cca.2015.03.005","article-title":"Cervical cancer: biomarkers for diagnosis and treatment","volume":"445","author":"Dasari","year":"2015","journal-title":"Clinica Chimica Acta"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55070384","article-title":"Key molecular events in cervical cancer development","volume":"55","author":"Balasubramaniam","year":"2019","journal-title":"Med (Lithuania)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103178","article-title":"Molecular landscape of recurrent cervical cancer","volume":"157","author":"Adiga","year":"2021","journal-title":"Crit Rev Oncology\/Hematology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.767931","article-title":"From microbiome to inflammation: the key drivers of cervical cancer","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Microbiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212571","article-title":"Cervical carcinoma: oncobiology and biomarkers","volume":"22","author":"Volkova","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1159\/000517320","article-title":"Inflammatory biomarkers as promising predictors of prognosis in cervical cancer patients","volume":"99","author":"Domenici","year":"2021","journal-title":"Oncology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1351736","article-title":"Novel biomarkers of inflammation-associated immunity in cervical cancer","volume":"14","author":"Zhao","year":"2024","journal-title":"Front Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol32010039","article-title":"Comprehensive evaluation of inflammatory biomarkers in cervical cancer treated with chemoradiotherapy","volume":"32","author":"Koca","year":"2025","journal-title":"Curr Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000001103","article-title":"Genetic predisposition to cervical cancer and the association with XRCC1 and TGFB1 polymorphisms","volume":"27","author":"Al-Harbi","year":"2017","journal-title":"Int J Gynecological Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27823","article-title":"Association of TNF-308 G>A polymorphism located in tumor necrosis factor a with the risk of developing cervical cancer and results of pap smear","volume":"120","author":"Babapour","year":"2019","journal-title":"J Cell Biochem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.145933","article-title":"Association of a genetic variant in interleukin-10 gene with increased risk and inflammation associated with cervical cancer","volume":"807","author":"Khorrami","year":"2022","journal-title":"Gene"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247055","article-title":"Statistical meta-analysis to investigate the association between the interleukin-6 (IL-6) gene polymorphisms and cancer risk","volume":"16","author":"Harun-Or-Roshid","year":"2021","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31539","article-title":"Cervical cancer risk in HPV-positive women after a negative FAM19A4\/mir124-2 methylation test: a post hoc analysis in the POBASCAM trial with 14 year follow-up","volume":"143","author":"De Strooper","year":"2018","journal-title":"Int J Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ijc.33320","article-title":"Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: a large European multicenter study","volume":"148","author":"Bonde","year":"2021","journal-title":"Int J Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2174\/1568009620666200102123635","article-title":"Hypermethylation of single CpG dinucleotides at the promoter of CXCL13 gene promoting cell migration in cervical cancer","volume":"20","author":"Ma","year":"2020","journal-title":"Curr Cancer Drug Targets"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6519427","article-title":"Role of regulatory B cells in the progression of cervical cancer","volume":"2019","author":"Chen","year":"2019","journal-title":"Mediators Inflammation"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2018\/e679","article-title":"Relationships of interleukin-10 with the regulatory T cell ratio and prognosis of cervical cancer patients","volume":"73","author":"Wang","year":"2018","journal-title":"Clinics (Sao Paulo Brazil)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2019.20.9.2715","article-title":"Reduced expression of IL-1\u03b2 and IL-18 proinflammatory interleukins increases the risk of developing cervical cancer","volume":"20","author":"Matamoros","year":"2019","journal-title":"Asian Pacific J Cancer Prev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2474235","article-title":"miR-9, miR-21, miR-27b, and miR-34a expression in HPV16\/58\/52-infected cervical cancer","volume":"2020","author":"Liu","year":"2020","journal-title":"BioMed Res Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6650966","article-title":"MicroRNA biomarkers of high-grade cervical intraepithelial neoplasia in liquid biopsy","volume":"2021","author":"Causin","year":"2021","journal-title":"BioMed Res Int"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4947381","article-title":"Identification of circulating microRNAs as a promising diagnostic biomarker for cervical intraepithelial neoplasia and early cancer: a meta-analysis","volume":"2020","author":"Jiang","year":"2020","journal-title":"BioMed Res Int"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.36740\/wlek202109210","article-title":"Role of microrna-155 as a diagnostic biomarker for human papillomavirus associated cervical cancer","volume":"74","author":"Jihad","year":"2021","journal-title":"Wiadomosci Lekarskie (Warsaw Poland: 1960)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201806_15251","article-title":"MicroRNA-155 regulates cervical cancer via inducing Th17\/Treg imbalance","volume":"22","author":"Zhang","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"10323","DOI":"10.1038\/s41598-021-89388-w","article-title":"Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer","volume":"11","author":"Aftab","year":"2021","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2021.22.4.1271","article-title":"Pap smear miR-92a-5p and miR-155-5p as potential diagnostic biomarkers of squamous intraepithelial cervical cancer","volume":"22","author":"Azimi","year":"2021","journal-title":"Asian Pacific J Cancer Prev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.7150\/jca.51141","article-title":"6 circulating miRNAs can be used as non-invasive biomarkers for the detection of cervical lesions","volume":"12","author":"Ning","year":"2021","journal-title":"J Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-021-00644-7","article-title":"Long noncoding RNA SNHG3 promotes Malignant phenotypes in cervical cancer cells via association with YAP1","volume":"35","author":"Zhu","year":"2021","journal-title":"Hum Cell"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112929","article-title":"Long non-coding RNA ABHD11-AS1 facilitates the progression of cervical cancer by competitively binding to miR-330-5p and upregulating MARK2","volume":"410","author":"Hou","year":"2021","journal-title":"Exp Cell Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.691140","article-title":"SPINT1-AS1 drives cervical cancer progression via repressing miR-214 biogenesis","volume":"9","author":"Song","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2217\/epi-2020-0437","article-title":"Identification of an immune signature to predict poor clinical outcome in cervical cancer","volume":"13","author":"Yan","year":"2021","journal-title":"Epigenomics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41419-020-2607-9","article-title":"Circular RNA circNRIP1 promotes migration and invasion in cervical cancer by sponging miR-629-3p and regulating the PTP4A1\/ERK1\/2 pathway","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1089\/cbr.2019.3159","article-title":"Circ_0000388 exerts oncogenic function in cervical cancer cells by regulating miR-337-3p\/TCF12 axis","volume":"36","author":"Meng","year":"2021","journal-title":"Cancer Biother Radiopharm"},{"key":"B38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13046-021-01849-2","article-title":"The circular RNA circZFR phosphorylates Rb promoting cervical cancer progression by regulating the SSBP1\/CDK2\/cyclin E1 complex","volume":"40","author":"Zhou","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.775006","article-title":"Identification of potential hub genes and miRNA-mRNA pairs related to the progression and prognosis of cervical cancer through integrated bioinformatics analysis","volume":"12","author":"Fu","year":"2021","journal-title":"Front Genet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41419-019-1748-1","article-title":"Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment","volume":"10","author":"Chen","year":"2019","journal-title":"Cell Death Dis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13854","article-title":"Plasma levels and tissue expression of selected cytokines, metalloproteinases and tissue inhibitors in patients with cervical cancer","volume":"39","author":"Sidorkiewicz","year":"2019","journal-title":"Anticancer Res"},{"key":"B42","article-title":"Stem cell index in the progression of cervical intraepithelial neoplasia","author":"Pkhakadze","year":"2021","journal-title":"Georgian Med News"},{"key":"B43","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12885-016-2364-4","article-title":"Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study","volume":"16","author":"Torres-Poveda","year":"2016","journal-title":"BMC Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104559","article-title":"Cytokine gene variants and socio-demographic characteristics as predictors of cervical cancer: a machine learning approach","volume":"134","author":"Kaushik","year":"2021","journal-title":"Comput Biol Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5028-8","article-title":"Transforming growth factor-\u03b21 in carcinogenesis, progression, and therapy in cervical cancer","volume":"37","author":"Zhu","year":"2016","journal-title":"Tumour Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12032-023-02204-5","article-title":"TGF-\u03b2 in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer","volume":"40","author":"Singh","year":"2023","journal-title":"Med Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.903679","article-title":"Tumor necrosis factor \u03b1: taking a personalized road in cancer therapy","volume":"13","author":"Ben-Baruch","year":"2022","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1080\/08820139.2020.1778023","article-title":"Association of polymorphisms in cytokine genes with susceptibility to precancerous lesions and cervical cancer: a systematic review with meta-analysis","volume":"50","author":"de Moura","year":"2021","journal-title":"Immunol Invest"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2020.21.5.1197","article-title":"Association of IL-12B rs3212227 and IL-6 rs1800795 polymorphisms with susceptibility to cervical cancer: a systematic review and meta-analysis","volume":"21","author":"Karimi-Zarchi","year":"2020","journal-title":"Asian Pacific J Cancer Prev"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2015.05.028","article-title":"IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians","volume":"76","author":"Zidi","year":"2015","journal-title":"Cytokine"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107131","article-title":"Detection of association of IL1\u03b2, IL4R, and IL6 gene polymorphisms with cervical cancer in the Bangladeshi women by tetra-primer ARMS-PCR method","volume":"90","author":"Muhammad","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3892\/br.2013.69","article-title":"The paradox of IL-10-mediated modulation in cervical cancer","volume":"1","author":"Wang","year":"2013","journal-title":"BioMed Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1186\/s12885-021-08743-2","article-title":"Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221\/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer","volume":"21","author":"Yang","year":"2021","journal-title":"BMC Cancer"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2019.0269","article-title":"Correlation between single nucleotide polymorphisms of an miRNA binding site in the 3\u2019UTR of PTEN and risk of cervical cancer among the Han Chinese","volume":"24","author":"Yu","year":"2020","journal-title":"Genet Test Mol Biomarkers"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening","author":"Wentzensen","year":"2016","journal-title":"J Clin Virol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32614","article-title":"FAM19A4\/miR124-2 methylation in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"147","author":"Vink","year":"2020","journal-title":"Int J Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.03.018","article-title":"FAM19A4\/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort","volume":"27","author":"Vink","year":"2021","journal-title":"Clin Microbiol Infection"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1186\/s12885-018-4877-5","article-title":"The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women","volume":"18","author":"Bu","year":"2018","journal-title":"BMC Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s10238-024-01508-8","article-title":"CXCL13: a common target for immune-mediated inflammatory diseases","volume":"24","author":"Hui","year":"2024","journal-title":"Clin Exp Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241482","article-title":"Downregulation of 5-hydroxymethylcytosine is associated with the progression of cervical intraepithelial neoplasia","volume":"15","author":"Kato","year":"2020","journal-title":"PLoS One"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrep.2021.101108","article-title":"Expression and clinical significance of UBE2V1 in cervical cancer","volume":"28","author":"Ren","year":"2021","journal-title":"Biochem Biophys Rep"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.774215","article-title":"Hypermethylated PCDHGB7 as a biomarker for early detection of endometrial cancer in endometrial brush samples and cervical scrapings","volume":"8","author":"Yuan","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32893","article-title":"Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead toward personalized treatment","volume":"147","author":"Lippens","year":"2020","journal-title":"Int J Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001254","article-title":"Expression of immune cell markers and tumor markers in patients with cervical cancer","volume":"30","author":"Zhang","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01218","article-title":"Pan-cancer analysis of immune cell infiltration identifies a prognostic immune-cell characteristic score (ICCS) in lung adenocarcinoma","volume":"11","author":"Zuo","year":"2020","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4017","article-title":"Immune correlates of therapy outcomes in women with cervical cancer treated with chemoradiotherapy: a systematic review","volume":"10","author":"Lakomy","year":"2021","journal-title":"Cancer Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","article-title":"MHC-II neoantigens shape tumour immunity and response to immunotherapy","volume":"574","author":"Alspach","year":"2019","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.142513","article-title":"PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells","volume":"6","author":"Balan\u00e7a","year":"2021","journal-title":"JCI Insight"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106884","article-title":"A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma","volume":"88","author":"Liu","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.145119","article-title":"Identification of prognosis-related genes in the cervical cancer immune microenvironment","volume":"766","author":"Yang","year":"2021","journal-title":"Gene"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106882","article-title":"Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer","volume":"88","author":"Mei","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.7804","article-title":"Correlation between subsets of tumor-infiltrating immune cells and risk stratification in patients with cervical cancer","volume":"7","author":"Chen","year":"2019","journal-title":"PeerJ"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.622643","article-title":"Immune-inhibitory gene expression is positively correlated with overall immune activity and predicts increased survival probability of cervical and head and neck cancer patients","volume":"8","author":"Budhwani","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s10517-014-2665-z","article-title":"Dynamics of proinflammatory cytokine levels and their role in the development of local and systemic effects during progressing cervical cancer","volume":"157","author":"Gening","year":"2014","journal-title":"Bull Exp Biol Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.612547","article-title":"Nocardia rubra cell wall skeleton up-regulates T cell subsets and inhibits PD-1\/PD-L1 pathway to promote local immune status of patients with high-risk human papillomavirus infection and cervical intraepithelial neoplasia","volume":"11","author":"Chen","year":"2020","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9481","article-title":"Th17 response in patients with cervical cancer","volume":"16","author":"Alves","year":"2018","journal-title":"Oncol Lett"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2018.4503","article-title":"Interleukin-17A and heparanase promote angiogenesis and cell proliferation and invasion in cervical cancer","volume":"53","author":"Lv","year":"2018","journal-title":"Int J Oncol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1080\/1547691X.2020.1755397","article-title":"Circulating inflammatory markers in cervical cancer patients and healthy controls","volume":"17","author":"Vitkauskaite","year":"2020","journal-title":"J Immunotoxicol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.12659\/msm.898569","article-title":"Expression of IL-1\u03b1 and IL-6 is associated with progression and prognosis of human cervical cancer","volume":"22","author":"Song","year":"2016","journal-title":"Med Sci Monitor"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2019.09.009","article-title":"Th9 cytokines curb cervical cancer progression and immune evasion","volume":"80","author":"Chauhan","year":"2019","journal-title":"Hum Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-0744-0","article-title":"GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1\/2 through the receptor ErbB2","volume":"37","author":"Li","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000004352","article-title":"Inflammation, immunity, and invasion: the pivotal role of cytokine storms in cervical carcinogenesis","volume":"88","author":"Obeagu","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.2174\/092986710793176348","article-title":"Interleukin-18: biology and role in the immunotherapy of cancer","volume":"17","author":"Srivastava","year":"2010","journal-title":"Curr Med Chem"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0776","article-title":"Immune activation in patients with locally advanced cervical cancer treated with ipilimumab following definitive chemoradiation (GOG-9929)","volume":"26","author":"Da Silva","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1159\/000508015","article-title":"Downregulation of IL-2 and IL-23 in cervical biopsies of cervical intraepithelial lesions: a cross-sectional study","volume":"64","author":"Petrini","year":"2020","journal-title":"Acta Cytologica"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.153159","article-title":"Identification of microRNA expression signature for the diagnosis and prognosis of cervical squamous cell carcinoma","volume":"216","author":"Bozgeyik","year":"2020","journal-title":"Pathol Res Pract"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-021-00818-9","article-title":"Expression of miR-34a and miR-15b during the progression of cervical cancer in a murine model expressing the HPV16 E7 oncoprotein","volume":"77","author":"Ocadiz-Delgado","year":"2021","journal-title":"J Physiol Biochem"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.21123","article-title":"Role of microRNAs as biomarkers of cervical carcinogenesis: a systematic review","volume":"64","author":"Nagandla","year":"2021","journal-title":"Obstetrics Gynecology Sci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/apm.13093","article-title":"Circulating miR-15b, miR-34a and miR-218 as promising novel early low-invasive biomarkers of cervical carcinogenesis","volume":"129","author":"Ocadiz-Delgado","year":"2021","journal-title":"APMIS"},{"key":"B92","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1186\/s12885-019-6066-6","article-title":"Plasma expression of miRNA-21, -\u2009214, -34a, and -200a in patients with persistent HPV infection and cervical lesions","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Cancer"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2019.0147","article-title":"Serum miR-638 combined with squamous cell carcinoma-related antigen as potential screening biomarkers for cervical squamous cell carcinoma","volume":"24","author":"Zheng","year":"2020","journal-title":"Genet Test Mol Biomarkers"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202006_21643","article-title":"Expression level of miRNA-210-3p in cervical cancer and its prognostic potential","volume":"24","author":"Shao","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-020-00852-w","article-title":"Increased miR-20b level in high grade cervical intraepithelial neoplasia","volume":"26","author":"Szekercz\u00e9s","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112277","article-title":"Human papillomavirus type 16 E7 oncoprotein-induced upregulation of lysine-specific demethylase 5A promotes cervical cancer progression by regulating the microRNA-424-5p\/suppressor of zeste 12 pathway","volume":"396","author":"Liu","year":"2020","journal-title":"Exp Cell Res"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2018.04.005","article-title":"MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer","volume":"99","author":"Wang","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2019.1614013","article-title":"MiR-34b regulates cervical cancer cell proliferation and apoptosis","volume":"47","author":"Cao","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-201021","article-title":"Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer","volume":"32","author":"Yamanaka","year":"2021","journal-title":"Cancer Biomarkers: Section A Dis Markers"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820970667","article-title":"A novel circulating miRNA-based signature for the diagnosis and prognosis prediction of early-stage cervical cancer","volume":"19","author":"Qiu","year":"2020","journal-title":"Technol Cancer Res Treat"},{"key":"B101","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3233\/CBM-190256","article-title":"Circulating plasma microRNA signature for the diagnosis of cervical cancer","volume":"26","author":"Ma","year":"2019","journal-title":"Cancer Biomarkers"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3929435","article-title":"The abnormal expression of miR-205-5p, miR-195-5p, and VEGF-A in human cervical cancer is related to the treatment of venous thromboembolism","volume":"2020","author":"Wang","year":"2020","journal-title":"BioMed Res Int"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153435","article-title":"MiR-25 and KLF4 relationship has early prognostic significance in the development of cervical cancer","volume":"222","author":"Yucel Polat","year":"2021","journal-title":"Pathol Res Pract"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2020.103211","article-title":"MiR-195-3p inhibits cell proliferation in cervical cancer by targeting BCDIN3D","volume":"143","author":"Jin","year":"2021","journal-title":"J Reprod Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13010063","article-title":"miRNA expression signatures of therapy response in squamous cell carcinomas","volume":"13","author":"Fekete","year":"2020","journal-title":"Cancers"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13184","article-title":"miR-200a\/b\/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer","volume":"16","author":"Nilsen","year":"2022","journal-title":"Mol Oncol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2020.12.006","article-title":"A ceRNA network of BBOX1-AS1-hsa-miR-125b-5p\/hsa-miR-125a-5p-CDKN2A shows prognostic value in cervical cancer","volume":"60","author":"Wang","year":"2021","journal-title":"Taiwanese J Obstetrics Gynecology"},{"key":"B108","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3892\/ol.2020.12316","article-title":"Circulating exosomal miR-125a-5p as a novel biomarker for cervical cancer","volume":"21","author":"Lv","year":"2021","journal-title":"Oncol Lett"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1159\/000520980","article-title":"Identification of miR-885-5p as a tumor biomarker: regulation of cellular function in cervical cancer","volume":"86","author":"Zu","year":"2021","journal-title":"Gynecologic Obstetric Invest"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200717","article-title":"Potential biomarkers and therapeutic targets in cervical cancer: insights from the meta-analysis of transcriptomics data within network biomedicine perspective","volume":"13","author":"Kori","year":"2018","journal-title":"PLoS One"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011020","article-title":"Inhibition of BIRC2 sensitizes \u03b17-HPV-related cervical squamous cell carcinoma to chemotherapy","volume":"22","author":"Lin","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1166\/jbn.2021.3138","article-title":"Polymerase chain reaction in the detection of miR-455-5p and sphingosine-1 phosphate proteins in cervical carcinoma with the help of gold nanoparticles-based","volume":"17","author":"Chen","year":"2021","journal-title":"J BioMed Nanotechnol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1186\/s12885-021-08331-4","article-title":"Hsa_circ_0000301 facilitates the progression of cervical cancer by targeting miR-1228-3p\/IRF4 axis","volume":"21","author":"Deng","year":"2021","journal-title":"BMC Cancer"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3967\/bes2021.026","article-title":"MicroRNA-378a-3p downregulation as a novel biomarker with poor clinical outcomes in cervical cancer","volume":"34","author":"Zhang","year":"2021","journal-title":"Biomed Environ Sciences: BES"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.12.034","article-title":"Cancer-secreted exosomal miR-1468-5p promotes tumor immune escape via the immunosuppressive reprogramming of lymphatic vessels","volume":"29","author":"Zhou","year":"2021","journal-title":"Mol Ther"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109654","article-title":"Folate inhibits miR-27a-3p expression during cervical carcinoma progression and oncogenic activity in human cervical cancer cells","volume":"122","author":"Wang","year":"2020","journal-title":"Biomedicine Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"B117","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1080\/21655979.2021.1890377","article-title":"Identification and validation of potential mRNA-microRNA-long-noncoding RNA (mRNA-miRNA-lncRNA) prognostic signature for cervical cancer","volume":"12","author":"Wang","year":"2021","journal-title":"Bioengineered"},{"key":"B118","doi-asserted-by":"publisher","first-page":"16584","DOI":"10.1038\/s41598-020-73523-0","article-title":"Transcriptome analysis uncovers the diagnostic value of miR-192-5p\/HNF1A-AS1\/VIL1 panel in cervical adenocarcinoma","volume":"10","author":"Xu","year":"2020","journal-title":"Sci Rep"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1177\/1533033821989711","article-title":"Dysregulated lncRNAs act as competitive endogenous RNAs and are associated with cervical cancer development in Uyghur women","volume":"20","author":"Chen","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_256_17","article-title":"Long noncoding RNA activated by transforming growth factor-\u03b2 promotes cancer development and is a prognostic marker in cervical cancer","volume":"13","author":"Cao","year":"2017","journal-title":"J Cancer Res Ther"},{"key":"B121","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s12935-021-02103-7","article-title":"LncRNA HOTAIR promotes proliferation and inhibits apoptosis by sponging miR-214-3p in HPV16 positive cervical cancer cells","volume":"21","author":"Zhou","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.2174\/2211536610666210604123534","article-title":"MicroRNA levels in cervical cancer samples and relationship with lesion grade and HPV infection","volume":"10","author":"Hoelzle","year":"2021","journal-title":"MicroRNA (Shariqah United Arab Emirates)"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166172","article-title":"Comprehensive analysis of ceRNA networks in HPV16- and HPV18-mediated cervical cancers reveals XIST as a pivotal competing endogenous RNA","volume":"1867","author":"Berti","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1947174","article-title":"The promotion of cervical cancer progression by signal transducer and activator of transcription 1-induced up-regulation of lncRNA MEOX2-AS1 as a competing endogenous RNA through miR-143-3p\/VDAC1 pathway","volume":"12","author":"Liu","year":"2021","journal-title":"Bioengineered"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1177\/1533033821995281","article-title":"Diagnostic value of vaginal microecology, serum miR-18a, and PD-L1 for identifying HPV-positive cervical cancer","volume":"20","author":"Zhang","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2022.12593","article-title":"Survival-related DLEU1 is associated with HPV infection status and serves as a biomarker in HPV-infected cervical cancer","volume":"25","author":"Dong","year":"2022","journal-title":"Mol Med Rep"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820971669","article-title":"DARS-AS1 knockdown inhibits the growth of cervical cancer cells via downregulating HMGB1 via sponging miR-188-5p","volume":"19","author":"Zhu","year":"2020","journal-title":"Technol Cancer Res Treat"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3280","article-title":"LINC01089 inhibits the progression of cervical cancer via inhibiting miR-27a-3p and increasing BTG2","volume":"23","author":"Li","year":"2021","journal-title":"J Gene Med"},{"key":"B129","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1186\/s12885-020-07441-9","article-title":"HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Cancer"},{"key":"B130","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jcb.29701","article-title":"REST-repressed lncRNA NPPA-AS1 regulates cervical cancer progression by modulating miR-302e\/DKK1\/Wnt\/\u03b2-catenin signaling pathway","volume":"122","author":"Luan","year":"2021","journal-title":"J Cell Biochem"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29846","article-title":"SP1-induced lncRNA FOXD3-AS1 contributes to tumorigenesis of cervical cancer by modulating the miR-296-5p\/HMGA1 pathway","volume":"122","author":"Ma","year":"2021","journal-title":"J Cell Biochem"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20200784","article-title":"Long non-coding RNA RP11-284F21.9 functions as a ceRNA regulating PPWD1 by competitively binding to miR-769-3p in cervical carcinoma","volume":"40","author":"Han","year":"2020","journal-title":"Biosci Rep"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202000762R","article-title":"HPV16 E6 oncoprotein-induced upregulation of lncRNA GABPB1-AS1 facilitates cervical cancer progression by regulating miR-519e-5p\/Notch2 axis","volume":"34","author":"Ou","year":"2020","journal-title":"FASEB J"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29472","article-title":"LINC00958 facilitates cervical cancer cell proliferation and metastasis by sponging miR-625-5p to upregulate LRRC8E expression","volume":"121","author":"Wang","year":"2020","journal-title":"J Cell Biochem"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29447","article-title":"LINC00116 enhances cervical cancer tumorigenesis through miR-106a\/c-Jun pathway","volume":"121","author":"Lai","year":"2020","journal-title":"J Cell Biochem"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201901_16862","article-title":"Higher lncRNA CASC15 expression predicts poor prognosis and associates with tumor growth in cervical cancer","volume":"23","author":"Shan","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-020-00149-y","article-title":"lncRNA NR2F1-AS1 regulates miR-17\/SIK1 axis to suppress the invasion and migration of cervical squamous cell carcinoma cells","volume":"27","author":"Peng","year":"2020","journal-title":"Reprod Sci (Thousand Oaks Calif)"},{"key":"B138","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2019.12.038","article-title":"Natural killer T cell cytotoxic activity in cervical cancer is facilitated by the LINC00240\/microRNA-124-3p\/STAT3\/MICA axis","volume":"474","author":"Zhang","year":"2020","journal-title":"Cancer Lett"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027404","article-title":"The profile analysis of circular RNAs in cervical cancer","volume":"100","author":"Huang","year":"2021","journal-title":"Medicine"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.618753","article-title":"Integrated analysis of ceRNA regulatory network associated with tumor stage in cervical cancer","volume":"12","author":"Ma","year":"2021","journal-title":"Front Genet"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.603516","article-title":"Genome-wide analysis of the expression of circular RNA full-length transcripts and construction of the circRNA-miRNA-mRNA network in cervical cancer","volume":"8","author":"Xu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.590627","article-title":"Hsa_circ_0107593 suppresses the progression of cervical cancer via sponging hsa-miR-20a-5p\/93-5p\/106b-5p","volume":"10","author":"Liao","year":"2020","journal-title":"Front Oncol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202518","article-title":"Circular RNA circEPSTI1 accelerates cervical cancer progression via miR-375\/409-3P\/515-5p-SLC7A11 axis","volume":"13","author":"Wu","year":"2021","journal-title":"Aging"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2020-0074","article-title":"Building a circular RNA centered gene regulation network associated with cervical squamous cell carcinoma","volume":"12","author":"Hu","year":"2020","journal-title":"Epigenomics"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103679","article-title":"Circular RNA circ_PVT1 induces epithelial-mesenchymal transition to promote metastasis of cervical cancer","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgaa046","article-title":"The use of micro RNA in the early detection of cervical intraepithelial neoplasia","volume":"41","author":"Wittenborn","year":"2020","journal-title":"Carcinogenesis"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgaa025","article-title":"MicroRNA-135a-induced formation of CD133+ subpopulation with cancer stem cell properties in cervical cancer","volume":"41","author":"Leung","year":"2020","journal-title":"Carcinogenesis"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1186\/s12885-019-6269-x","article-title":"CircAGFG1 promotes cervical cancer progression via miR-370-3p\/RAF1 signaling","volume":"19","author":"Wu","year":"2019","journal-title":"BMC Cancer"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.2174\/1389200221666200103113330","article-title":"Role of adiponectin in cervical cancer","volume":"20","author":"Soumya","year":"2019","journal-title":"Curr Drug Metab"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112335","article-title":"Cervical cancer progression is regulated by SOX transcription factors: Revealing signaling networks and therapeutic strategies","volume":"144","author":"Paskeh","year":"2021","journal-title":"Biomedicine Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-2772-5","article-title":"Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis","volume":"36","author":"Guo","year":"2015","journal-title":"Tumour Biol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.05.026","article-title":"Minicircles for a two-step blood biomarker and PET imaging early cancer detection strategy","volume":"335","author":"Robinson","year":"2021","journal-title":"J Controlled Release"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201909_18837","article-title":"MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5","volume":"23","author":"Wei","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.7150\/thno.44868","article-title":"FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10564","article-title":"RAD18 contributes to the migration and invasion of human cervical cancer cells via the interleukin-1\u03b2 pathway","volume":"20","author":"Lou","year":"2019","journal-title":"Mol Med Rep"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9146","article-title":"Analysis of deubiquitinase OTUD5 as a biomarker and therapeutic target for cervical cancer by bioinformatic analysis","volume":"8","author":"Bai","year":"2020","journal-title":"PeerJ"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2021.106000","article-title":"HDAC6 suppresses microRNA-199a transcription and augments HPV-positive cervical cancer progression through Wnt5a upregulation","volume":"136","author":"Shao","year":"2021","journal-title":"Int J Biochem Cell Biol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1186\/s12885-020-07241-1","article-title":"USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via activating AKT signaling pathway","volume":"20","author":"Diao","year":"2020","journal-title":"BMC Cancer"},{"key":"B159","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1186\/s12885-021-08674-y","article-title":"Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer","volume":"21","author":"Wu","year":"2021","journal-title":"BMC Cancer"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8494260","article-title":"Bioinformatics analysis reveals MCM3 as an important prognostic marker in cervical cancer","volume":"2021","author":"Ma","year":"2021","journal-title":"Comput Math Methods Med"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20204394","article-title":"Five candidate biomarkers associated with the diagnosis and prognosis of cervical cancer","volume":"41","author":"Han","year":"2021","journal-title":"Biosci Rep"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1111\/aji.13394","article-title":"Triaging abnormal cervical cancer screening tests using p16INK4a detection by ELISA on fresh cervical samples","volume":"86","author":"Leung","year":"2021","journal-title":"Am J Reprod Immunol (New York NY 1989)"},{"key":"B163","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12885-020-07740-1","article-title":"TOP2A\/MCM2, p16(INK4a), and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesions","volume":"21","author":"Del Moral-Hern\u00e1ndez","year":"2021","journal-title":"BMC Cancer"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2021.1610006","article-title":"Serum Tie-1 is a valuable marker for predicting the progression and prognosis of cervical cancer","volume":"27","author":"Bai","year":"2021","journal-title":"Pathol Oncol Res"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33832","article-title":"Nuclear transport proteins are secreted by cancer cells and identified as potential novel cancer biomarkers","volume":"150","author":"van der Watt","year":"2022","journal-title":"Int J Cancer"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1080\/00365513.2020.1846209","article-title":"Prognostic utility of serum YKL-40 in patients with cervical cancer","volume":"80","author":"Roslind","year":"2020","journal-title":"Scand J Clin Lab Invest"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1159\/000510713","article-title":"Comprehensive identification of the human secretome as potential indicators in treatment outcome of HPV-positive and -negative cervical cancer patients","volume":"85","author":"Kong","year":"2020","journal-title":"Gynecologic Obstetric Invest"},{"key":"B168","doi-asserted-by":"publisher","first-page":"9033","DOI":"10.1038\/s41598-020-65850-z","article-title":"Applying serum proteins and microRNA as novel biomarkers for early-stage cervical cancer detection","volume":"10","author":"Du","year":"2020","journal-title":"Sci Rep"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.11120","article-title":"Comprehensive analysis of aberrantly expressed long non-coding RNAs, microRNAs, and mRNAs associated with the competitive endogenous RNA network in cervical cancer","volume":"22","author":"Chen","year":"2020","journal-title":"Mol Med Rep"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5478574","article-title":"The new biomarker for cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) based on public database mining","volume":"2020","author":"Ding","year":"2020","journal-title":"BioMed Res Int"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.21037\/apm-21-554","article-title":"The predictive value of postoperative C-reactive protein (CRP), procalcitonin (PCT) and triggering receptor expressed on myeloid cells 1 (TREM-1) for the early detection of pulmonary infection following laparoscopic general anesthesia for cervical cancer","volume":"10","author":"Liu","year":"2021","journal-title":"Ann Palliative Med"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176391","article-title":"Silencing PROK2 inhibits invasion of human cervical cancer cells by targeting MMP15 expression","volume":"21","author":"Wu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2019.08.021","article-title":"Identification and validation of a prognostic proteomic signature for cervical cancer","volume":"155","author":"Rader","year":"2019","journal-title":"Gynecologic Oncol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2019.30.e13","article-title":"The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification","volume":"30","author":"Guan","year":"2019","journal-title":"J Gynecologic Oncol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6743","article-title":"Effects of 60 kDa prolactin and estradiol on metabolism and cell survival in cervical cancer: Co-expression of their hormonal receptors during cancer progression","volume":"40","author":"Riera-Leal","year":"2018","journal-title":"Oncol Rep"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2018.9.22710","article-title":"The re-awakening of hCG expression. Its role in the diagnosis of cervical squamous cell carcinoma","volume":"39","author":"Bozdag","year":"2018","journal-title":"Saudi Med J"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2018.4432","article-title":"Early synergistic interactions between the HPV16-E7 oncoprotein and 17\u03b2-oestradiol for repressing the expression of Granzyme B in a cervical cancer model","volume":"53","author":"Mungu\u00eda-Moreno","year":"2018","journal-title":"Int J Oncol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-022-00679-4","article-title":"An integrated analysis of single-cell and bulk transcriptomics reveals EFNA1 as a novel prognostic biomarker for cervical cancer","volume":"35","author":"Shen","year":"2022","journal-title":"Hum Cell"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259096","article-title":"Expression analysis of p16 and TOP2A protein biomarkers in cervical cancer lesions and their correlation with clinico-histopathological characteristics in a referral hospital, Tanzania","volume":"16","author":"Zuberi","year":"2021","journal-title":"PLoS One"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15137","article-title":"FGF13 enhances resistance to platinum drugs by regulating hCTR1 and ATP7A via a microtubule-stabilizing effect","volume":"112","author":"Yu","year":"2021","journal-title":"Cancer Sci"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5512340","article-title":"PLOD2 is a potent prognostic marker and associates with immune infiltration in cervical cancer","volume":"2021","author":"Li","year":"2021","journal-title":"BioMed Res Int"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23793","article-title":"CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients","volume":"35","author":"Ma","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"B183","doi-asserted-by":"publisher","first-page":"837","DOI":"10.21037\/atm-21-87","article-title":"The relevance of plasma R-spondin 1 and Slit2 as predictive biomarkers in cervical cancer chemotherapy and radiotherapy","volume":"9","author":"Nie","year":"2021","journal-title":"Ann Trans Med"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.655302","article-title":"CD155 promotes the progression of cervical cancer cells through AKT\/mTOR and NF-\u03baB pathways","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4034","article-title":"PD-L1, PARP1, and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer","volume":"10","author":"Ji","year":"2021","journal-title":"Cancer Med"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.721030","article-title":"Pan-cancer analysis of PARP1 alterations as biomarkers in the prediction of immunotherapeutic effects and the association of its expression levels and immunotherapy signatures","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1111\/jog.14813","article-title":"Williams syndrome transcription factor promotes proliferation and invasion of cervical cancer cells by regulating PI3K\/Akt signaling pathway","volume":"47","author":"Jiang","year":"2021","journal-title":"J Obstetrics Gynaecology Res"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202001978","article-title":"A fifteen-gene classifier to predict neoadjuvant chemotherapy responses in patients with stage IB to IIB squamous cervical cancer","volume":"8","author":"Tian","year":"2021","journal-title":"Advanced Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6663367","article-title":"Upregulation of CDC7 associated with cervical cancer incidence and development","volume":"2021","author":"Wang","year":"2021","journal-title":"BioMed Res Int"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16461","article-title":"Lipid metabolism regulator human hydroxysteroid dehydrogenase-like 2 (HSDL2) modulates cervical cancer cell proliferation and metastasis","volume":"25","author":"Yang","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B191","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4103\/jcrt.JCRT_569_18","article-title":"Chemoradiation in locally advanced Ca Cx: Effect on NGAL levels","volume":"17","author":"Dhankhar","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2020.200611","article-title":"Increased ADAM12 expression predicts poor prognosis in cervical cancer patients before general anesthesia","volume":"67","author":"Ma","year":"2021","journal-title":"Clin Lab"},{"key":"B193","doi-asserted-by":"publisher","first-page":"18734","DOI":"10.1038\/s41598-020-72518-1","article-title":"Clinical implication of oncogenic somatic mutations in early-stage cervical cancer with radical hysterectomy","volume":"10","author":"Watanabe","year":"2020","journal-title":"Sci Rep"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-020-2269-y","article-title":"Diagnostic value of circulating PIGF in combination with Flt-1 in early cervical cancer","volume":"40","author":"Yang","year":"2020","journal-title":"Curr Med Sci"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14648","article-title":"Use of AKR1C1 and TKTL1 in the diagnosis of low-grade squamous intraepithelial lesions from Mexican women","volume":"40","author":"Sequeda-Ju\u00e1rez","year":"2020","journal-title":"Anticancer Res"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010051","article-title":"Mutation analysis of radioresistant early-stage cervical cancer","volume":"23","author":"Oike","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-20-0271","article-title":"Glutaminase inhibitors induce thiol-mediated oxidative stress and radiosensitization in treatment-resistant cervical cancers","volume":"19","author":"Rashmi","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"B198","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12967-020-02553-z","article-title":"Connecting METTL3 and intratumoural CD33(+) MDSCs in predicting clinical outcome in cervical cancer","volume":"18","author":"Ni","year":"2020","journal-title":"J Transl Med"},{"key":"B199","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12920-020-00800-2","article-title":"TOP2A and CENPF are synergistic master regulators activated in cervical cancer","volume":"13","author":"Yu","year":"2020","journal-title":"BMC Med Genomics"},{"key":"B200","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.canlet.2020.09.025","article-title":"HPV-induced Nurr1 promotes cancer aggressiveness, self-renewal, and radioresistance via ERK and AKT signaling in cervical cancer","volume":"497","author":"Wan","year":"2021","journal-title":"Cancer Lett"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.47356","article-title":"Potential mechanism of RRM2 for promoting cervical cancer based on weighted gene co-expression network analysis","volume":"17","author":"Wang","year":"2020","journal-title":"Int J Med Sci"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11040619","article-title":"Multicentre evaluation of Hepika test clinical accuracy in diagnosing HPV-induced cancer and precancerous lesions of the uterine cervix","volume":"11","author":"Gustinucci","year":"2021","journal-title":"Diagnostics (Basel Switzerland)"},{"key":"B203","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s12253-019-00626-z","article-title":"Diagnostic power of cytokine M-CSF, metalloproteinase 2 (MMP-2) and tissue inhibitor-2 (TIMP-2) in cervical cancer patients based on ROC analysis","volume":"26","author":"Lubowicka","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1177\/1010428318790363","article-title":"Plasma levels and diagnostic utility of macrophage-colony stimulating factor, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 as tumor markers in cervical cancer patients","volume":"40","author":"Zajkowska","year":"2018","journal-title":"Tumour Biol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bbrc.2018.05.183","article-title":"RHCG suppresses cervical cancer progression through inhibiting migration and inducing apoptosis regulated by TGF-\u03b21","volume":"503","author":"Wang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102429","article-title":"Prognostic genes in the tumor microenvironment in cervical squamous cell carcinoma","volume":"11","author":"Pan","year":"2019","journal-title":"Aging"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3354","article-title":"CUE-101, a novel E7-pHLA-IL2-Fc fusion protein, enhances tumor antigen-specific T-cell activation for the treatment of HPV16-driven Malignancies","volume":"26","author":"Quayle","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4651627","article-title":"HPV-16 infection is associated with a high content of CD39 and CD73 ectonucleotidases in cervical samples from patients with CIN-1","volume":"2019","author":"de Lourdes Mora-Garc\u00eda","year":"2019","journal-title":"Mediators Inflammation"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1177\/1535370220978899","article-title":"Rapid and ultrasensitive detection of circulating human papillomavirus E7 cell-free DNA as a cervical cancer biomarker","volume":"246","author":"Rungkamoltip","year":"2021","journal-title":"Exp Biol Med (Maywood NJ)"},{"key":"B210","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40425-019-0526-z","article-title":"Efficacy of PD-1 blockade in cervical cancer is related to a CD8(+)FoxP3(+)CD25(+) T-cell subset with operational effector functions despite high immune checkpoint levels","volume":"7","author":"Heeren","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210289","article-title":"Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women","volume":"14","author":"Dankai","year":"2019","journal-title":"PLoS One"},{"key":"B212","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.anndiagpath.2018.11.007","article-title":"Clinicopathological study of role of CD34 expressions in the stroma of premalignant and Malignant lesions of uterine cervix","volume":"38","author":"Aijaz","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203040","article-title":"Single-nucleus RNA sequencing and spatial transcriptomics reveal the immunological microenvironment of cervical squamous cell carcinoma","volume":"9","author":"Ou","year":"2022","journal-title":"Adv Sci"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006624","article-title":"Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer","volume":"11","author":"Disis","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-022-02945-1","article-title":"Multiparametric immune profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: an exploratory study of the CLAP trial","volume":"25","author":"Wang","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1177\/17588359231220510","article-title":"High CTLA-4 transcriptomic expression correlates with high expression of other checkpoints and with immunotherapy outcome","volume":"16","author":"Krishnamurthy","year":"2024","journal-title":"Ther Adv Med Oncol"},{"key":"B217","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1007\/s12672-025-02862-z","article-title":"Low pre-treatment neutrophil-to-lymphocyte ratio predicted a better survival in recurrent\/metastatic cervical cancer treated with PD-1\/PD-L1 inhibitors","volume":"16","author":"Li","year":"2025","journal-title":"Discov Oncol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2026.2664301","article-title":"Using peripheral blood indicators and T cells subsets to evaluate the efficacy of immunotherapy for advanced and recurrent cervical cancer","volume":"22","author":"Bai","year":"2026","journal-title":"Hum Vaccin Immunother"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1391524","article-title":"Targeted proteomics-determined multi-biomarker profiles developed classifier for prognosis and immunotherapy responses of advanced cervical cancer","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005288","article-title":"Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions","volume":"10","author":"Abdulrahman","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.1172\/JCI157726","article-title":"Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer","volume":"132","author":"Huang","year":"2022","journal-title":"J Clin Invest"},{"key":"B222","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12935-024-03257-w","article-title":"RNA-binding proteins signature is a favorable biomarker of prognosis, immunotherapy and chemotherapy response for cervical cancer","volume":"24","author":"Chen","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2026.37.e20","article-title":"Suppressor of TCR signaling 2 (Sts-2) as a potential immunotherapy target and prognostic biomarker in cervical cancer","volume":"37","author":"Chen","year":"2026","journal-title":"J Gynecol Oncol"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9109365","article-title":"GLTP is a potential prognostic biomarker and correlates with immunotherapy efficacy in cervical cancer","volume":"2022","author":"Shi","year":"2022","journal-title":"Dis Markers"},{"key":"B225","doi-asserted-by":"publisher","first-page":"78","DOI":"10.17305\/bjbms.2019.4359","article-title":"Tissue-based metabolomics reveals potential biomarkers for cervical carcinoma and HPV infection","volume":"20","author":"Abudula","year":"2020","journal-title":"Biomolecules Biomedicine"},{"key":"B226","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12672-024-00948-8","article-title":"High-throughput metabolomics identifies new biomarkers for cervical cancer","volume":"15","author":"Li","year":"2024","journal-title":"Discov Onc"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2020.02.49","article-title":"Exploring metabolomics biomarkers for evaluating the effectiveness of concurrent radiochemotherapy for cervical cancers","volume":"9","author":"Zhou","year":"2020","journal-title":"Transl Cancer Res"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1159\/000452240","article-title":"Racial\/ethnic disparities in cervical cancer screening and outcomes","volume":"60","author":"Musselwhite","year":"2016","journal-title":"Acta Cytologica"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnma.2020.03.002","article-title":"A review of cervical cancer: incidence and disparities","volume":"112","author":"Buskwofie","year":"2020","journal-title":"J Natl Med Assoc"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.22034\/APJCP.2018.19.4.875","article-title":"Educational interventions for cervical cancer screening behavior of women: a systematic review","volume":"19","author":"Naz","year":"2018","journal-title":"Asian Pacific J Cancer Prev"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftz048","article-title":"Association of human papillomavirus infection and inflammation in cervical cancer","volume":"77","author":"Hemmat","year":"2019","journal-title":"Pathog Dis"},{"key":"B232","doi-asserted-by":"publisher","first-page":"9994","DOI":"10.3892\/ol.2018.8566","article-title":"Systematic prediction of target genes and pathways in cervical cancer from microRNA expression data","volume":"15","author":"Chen","year":"2018","journal-title":"Oncol Lett"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02651-3","article-title":"Induction of systemic immune responses and reversion of immunosuppression in the tumor microenvironment by a therapeutic vaccine for cervical cancer","volume":"69","author":"Che","year":"2020","journal-title":"Cancer Immunology Immunotherapy"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1080\/14789450.2021.1980387","article-title":"Molecular markers for cervical cancer screening","volume":"18","author":"G\u00fczel","year":"2021","journal-title":"Expert Rev Proteomics"},{"key":"B235","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.sxmr.2019.09.005","article-title":"Cervical cancer screening: past, present, and future","volume":"8","author":"Bedell","year":"2020","journal-title":"Sexual Med Rev"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186515","article-title":"Markers of angiogenesis, lymphangiogenesis, and epithelial-mesenchymal transition (plasticity) in CIN and early invasive carcinoma of the cervix: exploring putative molecular mechanisms involved in early tumor invasion","volume":"21","author":"Kurmyshkina","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1806448\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:02:22Z","timestamp":1786622542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1806448\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":236,"alternative-id":["10.3389\/fonc.2026.1806448"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1806448","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"article-number":"1806448"}}